can you switch to tirzepatide from semaglutide Switching Tirzepatide: What to Expect — Affinity Whole Health Switching between weight-loss medications -

But it doesnt address the underlying hormonal driver

This is highlighted by the new European Association for the Study of Obesity (EASO) guidelines on obesity management via pharmacotherapy dividing obesity-related complications into either fat mass, or metabolic dysfunction associated comorbidities

In the diabetic group, there was an average body weight loss of 4.4% before discontinuation, and an additional 1.3% of body weight lost one year later, the study reports

Pharmacologic strategies to modulate or enhance the effects of insulin hold particular importance for combatting psychotropic-associated weight gain

GLP-1RAs have improved treatment by improving glucose regulation, supporting weight reduction, and decreasing cardiovascular risk